Generational Equity Advises Boca Biolistics in its Investment by Clairvest
Summary
Going forward, Boca will be led by two of its founders, Valentin Adia (CEO) and Michael Morris (COO), both of whom have rolled a significant portion of their equity alongside Clairvest. Under the current management team, Clairvest has initiated investments in 60 different platform companies and generated top quartile performance over an extended period. “Our investment in Boca is the result of a multi-year domain effort in the life sciences industry and represents a compelling opportunity to back an entrepreneurial management team. Boca plays an important role in advancing the development of novel pharmaceutical drugs and diagnostic devices and we are delighted to partner with Valentin and Michael,” said Sebastien Dhonte, Managing Director of Clairvest. Their six-step approach features strategic and tactical growth consulting, exit planning education, business valuation, value enhancement strategies, M&A transactional services, and wealth management.